Annual Net Income
-$55.19 M
-$927.33 M-106.33%
December 31, 2023
Summary
- As of February 8, 2025, TBPH annual net profit is -$55.19 million, with the most recent change of -$927.33 million (-106.33%) on December 31, 2023.
- During the last 3 years, TBPH annual net income has risen by +$222.82 million (+80.15%).
- TBPH annual net income is now -106.33% below its all-time high of $872.13 million, reached on December 31, 2022.
Performance
TBPH Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$12.70 M
+$3.83 M+23.18%
September 30, 2024
Summary
- As of February 8, 2025, TBPH quarterly net profit is -$12.70 million, with the most recent change of +$3.83 million (+23.18%) on September 30, 2024.
- Over the past year, TBPH quarterly net income has dropped by -$3.75 million (-41.88%).
- TBPH quarterly net income is now -101.39% below its all-time high of $916.63 million, reached on September 30, 2022.
Performance
TBPH Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$49.40 M
-$3.75 M-8.21%
September 30, 2024
Summary
- As of February 8, 2025, TBPH TTM net profit is -$49.40 million, with the most recent change of -$3.75 million (-8.21%) on September 30, 2024.
- Over the past year, TBPH TTM net income has increased by +$7.64 million (+13.40%).
- TBPH TTM net income is now -105.64% below its all-time high of $875.99 million, reached on March 31, 2023.
Performance
TBPH TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
TBPH Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -106.3% | -41.9% | +13.4% |
| 3 y3 years | +80.2% | +64.0% | +78.1% |
| 5 y5 years | +74.4% | +78.3% | +82.2% |
TBPH Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -106.3% | +72.3% | -101.4% | +60.4% | -105.6% | +75.2% |
| 5 y | 5-year | -106.3% | +80.2% | -101.4% | +84.7% | -105.6% | +82.7% |
| alltime | all time | -106.3% | +80.7% | -101.4% | +85.4% | -105.6% | +82.7% |
Theravance Biopharma Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$12.70 M(-23.2%) | -$49.40 M(+8.2%) |
| Jun 2024 | - | -$16.53 M(+41.7%) | -$45.65 M(+2.0%) |
| Mar 2024 | - | -$11.66 M(+37.1%) | -$44.77 M(-18.9%) |
| Dec 2023 | -$55.19 M(-106.3%) | -$8.51 M(-4.9%) | -$55.19 M(-3.2%) |
| Sep 2023 | - | -$8.95 M(-42.8%) | -$57.05 M(-106.6%) |
| Jun 2023 | - | -$15.64 M(-29.2%) | $868.54 M(-0.9%) |
| Mar 2023 | - | -$22.09 M(+113.2%) | $875.99 M(+0.4%) |
| Dec 2022 | $872.13 M(-537.3%) | -$10.36 M(-101.1%) | $872.13 M(+2.5%) |
| Sep 2022 | - | $916.63 M(<-9900.0%) | $850.46 M(-938.1%) |
| Jun 2022 | - | -$8.19 M(-68.4%) | -$101.48 M(-30.3%) |
| Mar 2022 | - | -$25.95 M(-19.0%) | -$145.69 M(-26.9%) |
| Dec 2021 | -$199.43 M(-28.3%) | -$32.03 M(-9.3%) | -$199.43 M(-11.7%) |
| Sep 2021 | - | -$35.31 M(-32.6%) | -$225.83 M(-14.5%) |
| Jun 2021 | - | -$52.41 M(-34.2%) | -$264.16 M(-3.8%) |
| Mar 2021 | - | -$79.68 M(+36.4%) | -$274.64 M(-1.2%) |
| Dec 2020 | -$278.02 M(+17.6%) | -$58.43 M(-20.7%) | -$278.02 M(-2.5%) |
| Sep 2020 | - | -$73.64 M(+17.1%) | -$285.19 M(+5.6%) |
| Jun 2020 | - | -$62.89 M(-24.3%) | -$269.98 M(+9.3%) |
| Mar 2020 | - | -$83.05 M(+26.6%) | -$246.93 M(+4.4%) |
| Dec 2019 | -$236.46 M(+9.7%) | -$65.61 M(+12.3%) | -$236.46 M(+7.0%) |
| Sep 2019 | - | -$58.43 M(+46.7%) | -$221.03 M(-0.5%) |
| Jun 2019 | - | -$39.84 M(-45.1%) | -$222.04 M(-0.4%) |
| Mar 2019 | - | -$72.58 M(+44.6%) | -$223.02 M(+3.5%) |
| Dec 2018 | -$215.52 M | -$50.19 M(-15.6%) | -$215.52 M(-14.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$59.43 M(+45.6%) | -$252.26 M(-2.9%) |
| Jun 2018 | - | -$40.82 M(-37.3%) | -$259.70 M(-8.9%) |
| Mar 2018 | - | -$65.09 M(-25.1%) | -$285.17 M(-0.1%) |
| Dec 2017 | -$285.40 M(+49.7%) | -$86.92 M(+30.0%) | -$285.40 M(+7.4%) |
| Sep 2017 | - | -$66.88 M(+0.9%) | -$265.82 M(+14.1%) |
| Jun 2017 | - | -$66.29 M(+1.5%) | -$232.90 M(+8.9%) |
| Mar 2017 | - | -$65.32 M(-3.0%) | -$213.84 M(+12.2%) |
| Dec 2016 | -$190.67 M(+4.6%) | -$67.33 M(+98.3%) | -$190.67 M(+13.4%) |
| Sep 2016 | - | -$33.96 M(-28.1%) | -$168.16 M(-7.4%) |
| Jun 2016 | - | -$47.23 M(+12.0%) | -$181.51 M(-0.2%) |
| Mar 2016 | - | -$42.15 M(-6.0%) | -$181.89 M(-0.2%) |
| Dec 2015 | -$182.22 M(-23.1%) | -$44.83 M(-5.3%) | -$182.22 M(-9.7%) |
| Sep 2015 | - | -$47.31 M(-0.6%) | -$201.70 M(-3.4%) |
| Jun 2015 | - | -$47.60 M(+12.1%) | -$208.88 M(-4.8%) |
| Mar 2015 | - | -$42.47 M(-34.0%) | -$219.49 M(-7.4%) |
| Dec 2014 | -$237.04 M(+51.7%) | -$64.31 M(+18.0%) | -$237.04 M(+9.3%) |
| Sep 2014 | - | -$54.49 M(-6.4%) | -$216.81 M(+6.6%) |
| Jun 2014 | - | -$58.22 M(-3.0%) | -$203.39 M(+10.5%) |
| Mar 2014 | - | -$60.02 M(+36.2%) | -$184.13 M(+17.8%) |
| Dec 2013 | -$156.28 M(+1532.2%) | -$44.08 M(+7.3%) | -$156.28 M(+39.3%) |
| Sep 2013 | - | -$41.08 M(+5.5%) | -$112.20 M(+57.8%) |
| Jun 2013 | - | -$38.95 M(+21.1%) | -$71.13 M(+121.1%) |
| Mar 2013 | - | -$32.17 M | -$32.17 M |
| Dec 2012 | -$9.57 M | - | - |
FAQ
- What is Theravance Biopharma annual net profit?
- What is the all time high annual net income for Theravance Biopharma?
- What is Theravance Biopharma annual net income year-on-year change?
- What is Theravance Biopharma quarterly net profit?
- What is the all time high quarterly net income for Theravance Biopharma?
- What is Theravance Biopharma quarterly net income year-on-year change?
- What is Theravance Biopharma TTM net profit?
- What is the all time high TTM net income for Theravance Biopharma?
- What is Theravance Biopharma TTM net income year-on-year change?
What is Theravance Biopharma annual net profit?
The current annual net income of TBPH is -$55.19 M
What is the all time high annual net income for Theravance Biopharma?
Theravance Biopharma all-time high annual net profit is $872.13 M
What is Theravance Biopharma annual net income year-on-year change?
Over the past year, TBPH annual net profit has changed by -$927.33 M (-106.33%)
What is Theravance Biopharma quarterly net profit?
The current quarterly net income of TBPH is -$12.70 M
What is the all time high quarterly net income for Theravance Biopharma?
Theravance Biopharma all-time high quarterly net profit is $916.63 M
What is Theravance Biopharma quarterly net income year-on-year change?
Over the past year, TBPH quarterly net profit has changed by -$3.75 M (-41.88%)
What is Theravance Biopharma TTM net profit?
The current TTM net income of TBPH is -$49.40 M
What is the all time high TTM net income for Theravance Biopharma?
Theravance Biopharma all-time high TTM net profit is $875.99 M
What is Theravance Biopharma TTM net income year-on-year change?
Over the past year, TBPH TTM net profit has changed by +$7.64 M (+13.40%)